Chémérine, visfatine, résistine et apeline : des adipokines impliquées dans la fertilité chez la femme ? (notice n° 755981)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03563cam a2200385 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123100312.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Estienne, Anthony |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Chémérine, visfatine, résistine et apeline : des adipokines impliquées dans la fertilité chez la femme ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2020.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 29 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Résumé Les adipokines sont des molécules exprimées et secrétées par le tissu adipeux blanc. Elles sont connues pour réguler l’homéostasie énergétique et la sensibilité à l’insuline mais aussi d’autres fonctions physiologiques comme l’angiogenèse, l’immunité et la reproduction. Outre la leptine et l’adiponectine, d’autres adipokines comme la chémérine, la visfatine, la résistine, et l’apeline sont de plus en plus étudiées en lien avec la fertilité. La plupart de ces hormones et de leurs récepteurs sont identifiés au niveau du tractus reproducteur chez la femme. Au niveau des cellules ovariennes, plusieurs études in vitro montrent qu’elles sont capables de réguler la sécrétion des stéroïdes, la prolifération et la viabilité cellulaire. Ces adipokines sont aussi présentes au niveau de l’utérus et du placenta et pourraient jouer un rôle dans les échanges entre le fœtus et la mère. Cette revue a pour objectifs de faire une synthèse des données de la littérature sur l’expression et les effets décrits de ces adipokines au niveau de l’ovaire, de l’utérus et du placenta dans des conditions normales et pathologiques (syndrome des ovaires polykystiques) et certaines pathologies de la gestation (diabète gestationnel, prééclampsie et retard de croissance in utero). |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Adipokines are molecules expressed and secreted by white adipose tissue. They are known to regulate energy homeostasis and insulin sensitivity but also other physiological functions such as angiogenesis, immunity and reproduction. In addition to leptin and adiponectin, other adipokines such as chemerin, visfatin, resistin, and apelin are increasingly being studied in connection with fertility. Most of these hormones and their receptors are found in the reproductive tract in women. In ovarian cells, several in vitro studies show that they are able to regulate steroid secretions, proliferation and cell viability. These adipokines are also present in the uterus and placenta and could play a role in the exchanges between the fetus and the mother. The objectives of this review are to summarize data from the literature on the expression and the described effects of these adipokines in the ovary, the uterus and the placenta under normal and pathological conditions (polycystic ovary syndrome and some pathologies of pregnancy (gestational diabetes, preeclampsia and intra-uterine growth retardation). |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | placenta |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | utérus |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | syndrome des ovaires polykystiques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | visfatine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chémérine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adipokines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | apeline |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | résistine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | placenta |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | polycystic ovary syndrome |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | visfatin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | uterus |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adipokines |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | resistin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chemerin |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | apelin |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bongrani, Alice |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dupont, Joëlle |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine de la Reproduction | 22 | 1 | 2020-01-01 | p. 66-77 | 2650-8427 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-medecine-de-la-reproduction-2020-1-page-66?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-medecine-de-la-reproduction-2020-1-page-66?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux